+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transfusion Diagnostics Market: Immunohematology and NAT Testing, 2019-2023-Supplier Shares by Country, Sales Forecasts and Strategic Profiles of Leading Suppliers

  • ID: 4173221
  • Report
  • July 2019
  • Region: Global
  • 60 pages
  • VPG Market Research
1 of 2

FEATURED COMPANIES

  • Abbott
  • Biokit
  • Diagast
  • Grifols
  • LabCorp
  • Quidel
  • MORE
This report provides a worldwide overview of the blood banking market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country.

The report also presents analyses of leading current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 60 pages and 5 tables
Note: Product cover images may vary from those shown
2 of 2
  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Diagast
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic
  • Immucor
  • LabCorp
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Quest Diagnostics
  • Quidel
  • Roche
  • Siemens Healthineers
  • Tecan
  • Thermo Fisher
Note: Product cover images may vary from those shown
Adroll
adroll